Library / Laws / 116th Congress / Senate Bills / S. 2074
S. 2074
To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification treatment, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2019-07-10 | 7.0K | ⠃⠗⠋ |